Product Code: ETC8842223 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The glaucoma market in the Philippines is expanding due to the rising prevalence of eye diseases, increasing awareness about early detection, and advancements in treatment options. With an aging population and growing cases of diabetes, glaucoma remains a major cause of irreversible blindness in the country. Government initiatives, improved healthcare infrastructure, and the availability of advanced diagnostic tools are contributing to market growth. However, challenges such as limited access to specialized eye care in rural areas and the high cost of treatment may hinder market expansion.
The increasing prevalence of glaucoma, particularly among the aging population, is a key driver of market growth in the Philippines. As the awareness of early detection and treatment of glaucoma rises, more individuals are seeking medical intervention to prevent vision loss. Advancements in diagnostic tools, improved access to ophthalmic care, and government initiatives focused on eye health are further fueling market expansion. Additionally, the increasing availability of innovative treatment options, including laser therapy and minimally invasive surgeries, is contributing to market demand.
The glaucoma market in the Philippines faces challenges due to low awareness and delayed diagnosis among patients. The high cost of glaucoma treatments, including medications and surgical procedures, limits access to care, especially in rural areas. Additionally, a shortage of specialized ophthalmologists and advanced treatment facilities affects early intervention and disease management. Government healthcare funding limitations also pose challenges for widespread treatment accessibility.
The increasing prevalence of glaucoma and the aging population in the Philippines are driving demand for advanced diagnostic and treatment options. Investment opportunities exist in ophthalmic drug development, specialized eye clinics, and medical device distribution for early glaucoma detection and management.
The Department of Health (DOH) implements policies to improve access to glaucoma diagnosis and treatment through public healthcare programs. The government subsidizes medications and surgical interventions for low-income patients. Research initiatives are supported to advance the development of new treatment options for glaucoma.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Glaucoma Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Glaucoma Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Glaucoma Market - Industry Life Cycle |
3.4 Philippines Glaucoma Market - Porter's Five Forces |
3.5 Philippines Glaucoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Glaucoma Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Philippines Glaucoma Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Glaucoma Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Philippines Glaucoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Glaucoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Glaucoma Market Trends |
6 Philippines Glaucoma Market, By Types |
6.1 Philippines Glaucoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Glaucoma Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Glaucoma Market Revenues & Volume, By Closed Angle Glaucoma (CAG), 2021- 2031F |
6.1.4 Philippines Glaucoma Market Revenues & Volume, By Open Angle Glaucoma (OAG), 2021- 2031F |
6.1.5 Philippines Glaucoma Market Revenues & Volume, By Secondary Glaucoma, 2021- 2031F |
6.1.6 Philippines Glaucoma Market Revenues & Volume, By Congenital Glaucoma, 2021- 2031F |
6.1.7 Philippines Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Glaucoma Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Philippines Glaucoma Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.2.3 Philippines Glaucoma Market Revenues & Volume, By Prostaglandins, 2021- 2031F |
6.2.4 Philippines Glaucoma Market Revenues & Volume, By Alpha Adrenergic Agonist, 2021- 2031F |
6.2.5 Philippines Glaucoma Market Revenues & Volume, By Carbonic Anhydrase Inhibitors, 2021- 2031F |
6.2.6 Philippines Glaucoma Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.7 Philippines Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Glaucoma Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Glaucoma Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Glaucoma Market Revenues & Volume, By Injections, 2021- 2031F |
6.3.4 Philippines Glaucoma Market Revenues & Volume, By Intravitreal, 2021- 2031F |
6.3.5 Philippines Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Glaucoma Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Glaucoma Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Glaucoma Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.4 Philippines Glaucoma Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Glaucoma Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Glaucoma Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Philippines Glaucoma Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Philippines Glaucoma Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Glaucoma Market Import-Export Trade Statistics |
7.1 Philippines Glaucoma Market Export to Major Countries |
7.2 Philippines Glaucoma Market Imports from Major Countries |
8 Philippines Glaucoma Market Key Performance Indicators |
9 Philippines Glaucoma Market - Opportunity Assessment |
9.1 Philippines Glaucoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Glaucoma Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Philippines Glaucoma Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Glaucoma Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Philippines Glaucoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Glaucoma Market - Competitive Landscape |
10.1 Philippines Glaucoma Market Revenue Share, By Companies, 2024 |
10.2 Philippines Glaucoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |